Good find weav. And good propaganda for Bayer. By the way, I know a little about Bayer products and notice that their propaganda sheet didn't mention that their clinical trial exceeded the standard, only that they know of other studies doing do. Fact is that Bayer's 2015 product, Contour Next, barely scraped by in the clinicals under the +/- 15% standard.
Also, what is left out is that the J&J Lifescan Ultra products are a part of the 20% (of strips/meters) that do not meet the standard, nor do several Roche products. And.... the standards for "new" products is much more strict, +/- 12% 97% of the time and +/- 14% 99% of the time. Bummer for making small improvements as manufacturers are want to do.
(2)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links